GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.

Employees

51,000

Sector

Advanced Medical Equipment & Technology

Calendar

2024-10-28 - Q3 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Quotes

Date	Price	Change	Volume
24-09-09	85.12 $	+0.04%	1,659,805
24-09-06	85.09 $	-2.52%	2,696,523
24-09-05	87.29 $	-0.30%	2,320,980
24-09-04	87.55 $	+3.24%	2,007,954

Delayed Quote Nasdaq, September 09, 2024 at 04:00 pm EDT

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

85.12USD

Average target price

94.96USD

Spread / Average Target

+11.56%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Market Closed - Nasdaq Other stock markets 04:00:00 2024-09-09 pm EDT			5-day change	1st Jan Change
85.12 ^USD	+0.04%		+0.35%	+10.09%

Sep. 09	JPMorgan Initiates GE HealthCare Technologies at Neutral With $90 Price Target	MT
Sep. 05	Transcript : GE HealthCare Technologies Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 01:05 PM

Capitalization	38.87B	P/E ratio 2024 *	21.3x	P/E ratio 2025 *	18.7x
Enterprise value	44.25B	EV / Sales 2024 *	2.24x	EV / Sales 2025 *	2.02x
Free-Float	93.14%	Yield 2024 *	0.13%	Yield 2025 *	0.14%

JPMorgan Initiates GE HealthCare Technologies at Neutral With $90 Price Target	Sep. 09	MT
Transcript : GE HealthCare Technologies Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 01:05 PM	Sep. 05
Transcript : GE HealthCare Technologies Inc. Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 10:15 AM	Sep. 04
Redburn Adjusts Price Target on GE HealthCare Technologies to $105 From $93, Maintains Buy Rating	Sep. 03	MT
GE HealthCare Secures CE Marks for Cardiac Imaging Systems	Aug. 26	MT
GE HealthCare: two technologies CE marked	Aug. 26	CF
GE HealthCare Technologies Inc. Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments At the Point of Care At ESC 2024	Aug. 26	CI
GE HealthCare Announces the Publication of the MASTER Trial Results in the Peer-Reviewed Journal Anesthesia and Analgesia	Aug. 20	CI
GE HealthCare to Embark on a Collaboration to Elevate Women's Imaging	Aug. 19	CI
Stifel Initiates GE HealthCare Technologies at Buy With $100 Price Target	Aug. 06	MT
China's stuttering recovery darkens global corporate growth outlook	Aug. 02	RE
Piper Sandler Adjusts Price Target on GE HealthCare Technologies to $95 From $92	Aug. 01	MT
Goldman Sachs Adjusts Price Target on GE HealthCare Technologies to $88 From $83	Aug. 01	MT

JPMorgan Initiates GE HealthCare Technologies at Neutral With $90 Price Target	Sep. 09	MT
Redburn Adjusts Price Target on GE HealthCare Technologies to $105 From $93, Maintains Buy Rating	Sep. 03	MT
Stifel Initiates GE HealthCare Technologies at Buy With $100 Price Target	Aug. 06	MT
Piper Sandler Adjusts Price Target on GE HealthCare Technologies to $95 From $92	Aug. 01	MT
Goldman Sachs Adjusts Price Target on GE HealthCare Technologies to $88 From $83	Aug. 01	MT

GE HealthCare Technologies Inc. Stock

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Valuation: GE HealthCare Technologies Inc.

Chart: GE HealthCare Technologies Inc.

Latest news: GE HealthCare Technologies Inc.

Last Transcript: GE HealthCare Technologies Inc.

Analysts' recommendations: GE HealthCare Technologies Inc.

Press Releases: GE HealthCare Technologies Inc.

News in other languages: GE HealthCare Technologies Inc.

Quotes and Performance

Course Extremes

Managers and Directors: GE HealthCare Technologies Inc.

ETFs: GE HealthCare Technologies Inc.

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly earnings, Rate of surprise

GE HealthCare Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments at the Point of Care at ESC 2024	Aug. 26	BU
GE HealthCare management to present at September investor conferences	Aug. 21	BU
Clinical Study Shows Targeted End-tidal Control Anesthesia Delivery Improves Efficiency and Accuracy to Help Optimize Patient Care	Aug. 20	BU
GE HealthCare to Embark on a Collaboration to Elevate Women’s Imaging	Aug. 19	BU
Fitch Rates GE Healthcare's Senior Unsecured Notes 'BBB'	Aug. 08	AQ

GE HealthCare : obtient la marquage CE pour deux technologies	Aug. 26
GE HealthCare aduce la debilidad del mercado chino para recortar las previsiones -- Market Talk	Jul. 31
Schwaches China-Geschäft bremst Siemens Healthineers - Am Dax-Ende	Jul. 31
GE HealthCare : hausse de 9% du BPA au 2e trimestre	Jul. 31
Trop tôt pour se la couler douce en bourse	Jul. 31

1 day	+0.04%
1 week	+0.35%
Current month	+0.35%
1 month	+2.06%
3 months	+11.50%
6 months	-9.32%
Current year	+10.09%

Director	Title	Age	Since
Peter Arduini CEO	Chief Executive Officer	59	22-12-13
James Saccaro DFI	Director of Finance/CFO	51	23-05-31
Jahid Khandaker CTO	Chief Tech/Sci/R&D Officer	-	22-09-30

Name	Weight	AuM	1st Jan change	Investor Rating
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - DIST - USD	0.07%	1,174 M€	+23.54%
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - ACC - USD	0.07%	655 M€	-.--%	-

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
GE HEALTHCARE TECHNOLOGIES INC.	+0.04%	+0.35%	+31.16%	-	38.87B
THERMO FISHER SCIENTIFIC INC.	+1.49%	+0.87%	+19.71%	+9.08%	237B
DANAHER CORPORATION	+2.59%	+1.40%	+9.96%	-16.84%	197B
INTUITIVE SURGICAL, INC.	+1.60%	-2.69%	+60.75%	+34.41%	170B
BOSTON SCIENTIFIC CORPORATION	+1.29%	+1.05%	+53.42%	+82.01%	122B
SIEMENS HEALTHINEERS AG	-0.18%	-4.01%	+10.45%	-12.73%	61.72B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.66%	-2.42%	-7.41%	-28.02%	40.89B
EDWARDS LIFESCIENCES CORPORATION	-1.65%	-6.07%	-11.29%	-46.17%	39.58B
AGILENT TECHNOLOGIES, INC.	+0.65%	-3.38%	+21.14%	-22.08%	39.68B
RESMED, INC.	+1.92%	+1.85%	+68.68%	-15.57%	36.67B
Average	+0.71%	-1.37%	+25.66%	-1.77%	98.37B
Weighted average by Cap.	+1.31%	-0.53%	+28.41%	+10.02%

Manager	Title	Age	Since
Peter Arduini CEO	Chief Executive Officer	59	22-12-13
Catherine Lesjak BRD	Director/Board Member	65	22-12-13
Rodney Hochman BRD	Director/Board Member	68	23-01-02

	2024 *	2025 *
Net sales	19.79B	20.81B
Net income	1.82B	2.09B
Net Debt	5.38B	3.2B